Inflammatory biomarkers in cerebral venous thrombosis versus ischemic stroke: a network meta-analysis

Xinlong Shen1,2, Ling Chen3, Liling Shen4

  • 1Department of Neurosurgery, Dongfang Affiliated Hospital of Xiamen University, School of Medicine, Xiamen University, Xiamen, Fujian, China.

Frontiers in Neurology
|December 12, 2025
PubMed

Insights

Cerebral venous thrombosis (CVT) and ischemic stroke (IS) share inflammatory markers, but CVT shows a stronger response. C-reactive protein (CRP) and Interleukin-6 (IL-6) are significantly higher in CVT, aiding differential diagnosis.

Area of Science:

  • Neurology
  • Immunology
  • Medical Diagnostics

Background:

  • Cerebrovascular diseases (CVD) management differs for ischemic stroke (IS) and cerebral venous thrombosis (CVT).
  • Inflammation-driven mechanisms in IS and CVT are not fully translated into individualized interventions.
  • Understanding shared and distinct inflammatory pathways is crucial for effective CVD management.

Purpose of the Study:

  • To compare inflammation-driven mechanisms in IS and CVT.
  • To identify potential inflammatory markers for differentiating IS from CVT.
  • To inform individualized treatment strategies for cerebrovascular diseases.

Main Methods:

  • Bayesian network meta-analysis of 18 eligible studies.
  • Searched PubMed, Embase, Web of Science, and Cochrane Library up to February 1, 2025.
  • Assessed evidence quality using the GRADE method; registered in PROSPERO (CRD42024539498).

Main Results:

  • Acute-phase inflammatory markers are elevated in both CVT and IS.
  • CVT exhibits a stronger systemic inflammatory response compared to IS.
  • C-reactive protein (CRP) and Interleukin-6 (IL-6) were significantly higher in acute CVT than IS.

Conclusions:

  • Inflammatory markers show both shared and distinct patterns in CVT and IS.
  • Elevated CRP and IL-6 in CVT suggest potential adjunctive diagnostic value.
  • Findings require prospective validation; neuroimaging remains the gold standard for diagnosis.
Abstract

Related Concept Videos

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
270
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
518
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
262